University hospitals Case Medical Center

Cleveland, Ohio 44126

4 studies enrolling now · 269 studies all time

What they study most

ADHD, Achalasia, Actinic Keratoses, Acute Coronary Syndrome, Acute Heart Failure, Acute Kidney Injury, Acute Lymphoblastic Leukemia (ALL), Acute Lymphoblastic Leukemia/Lymphoma, Acute Lymphoid Leukemia, Acute Myelogenous Leukemia, Acute Myelogenous Leukemia (AML or ANLL), Acute Myeloid Leukemia

Studies at this site

• A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) — Recruiting now
• A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• Sickle Cell Disease Biofluid Chip Technology (SCD BioChip) — Recruiting now
• A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib — Completed
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib (INCB050465) — Running, not enrolling
• Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). — Running, not enrolling
• A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer) — Stopped early
• Escalating Doses of Memantine in Down Syndrome (MEDS-123) — Starting soon
• A Study Comparing the Efficacy and Safety of Polatuzumab Vedotin With Rituximab-Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Diffuse Large B-Cell Lymphoma — Completed
• Medtronic Evolut Transcatheter Aortic Valve Replacement in Low Risk Patients — Running, not enrolling
• Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement — Completed
• Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) — Completed
• The Cleveland Cardiometabolic Cohort — Completed
• Pragmatic Randomized Trial of Proton vs. Photon Therapy for Patients With Non-Metastatic Breast Cancer: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial — Running, not enrolling
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• Selexipag (ACT-293987) in Pulmonary Arterial Hypertension — Completed
• TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure — Completed
• Portable Monitoring for Diagnosis and Management of Sleep Apnea — Completed
• Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder — Completed
• Connect® Myeloid Disease Registry — Stopped early
• Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year — Completed
• Multicenter Hologic Tomosynthesis Study — Completed
• Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions — Completed
• Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer — Completed
• Pediatric Adenotonsillectomy Trial for Snoring — Completed
• Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment — Stopped early
• A Study of TAS-116 in Patients With Solid Tumors — Completed
• To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs) — Completed
• Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs) — Completed
• Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) — Completed
• Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders — Completed
• A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders — Completed
• Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs) — Completed
• Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions — Completed
• Phase 3 Study to Treat Patients With Soft Tissue Sarcomas — Completed
• A Dose Escalation Study of L-DOS47 in Recurrent or Metastatic Non-Squamous NSCLC — Stopped early
• Direct Comparison of Spinal Cord Stimulator Parameter Settings — Completed
• Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen® — Stopped early
• Management of Reflux After Sleeve Using Stretta — Stopped early
• AdaptResponse Clinical Trial — Completed
• A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease — Stopped early
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) — Completed
• A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) — Completed
• Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT) — Completed
• Decision Aids to Improve Knowledge in Patients With Prostate Cancer — Completed
• Down Syndrome Memantine Follow-up Study — Completed
• Apathy in Dementia Methylphenidate Trial 2 — Completed